Pages that link to "Q28188116"
Jump to navigation
Jump to search
The following pages link to Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor (Q28188116):
Displaying 50 items.
- PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity (Q24316881) (← links)
- Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide (Q24529128) (← links)
- Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1 (Q27666429) (← links)
- Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer (Q28821362) (← links)
- Genomic organization, tissue distribution and functional characterization of the rat Pate gene cluster (Q30415080) (← links)
- Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group. (Q31038443) (← links)
- Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells. (Q31110978) (← links)
- Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region (Q33278178) (← links)
- Synthesis and characterization of an (111)In-labeled peptide for the in vivo localization of human cancers expressing the urokinase-type plasminogen activator receptor (uPAR) (Q33912826) (← links)
- Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging (Q34069767) (← links)
- Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty? (Q34182861) (← links)
- Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding. (Q34370103) (← links)
- Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment (Q34399577) (← links)
- First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts (Q34442512) (← links)
- Extracellular matrix-associated gene expression in adult sensory neuron populations cultured on a laminin substrate. (Q34566967) (← links)
- Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. (Q34766934) (← links)
- Epithelial progenitor 1, a novel factor associated with epithelial cell growth and differentiation (Q34889424) (← links)
- Members of the murine Pate family are predominantly expressed in the epididymis in a segment-specific fashion and regulated by androgens and other testicular factors (Q35339268) (← links)
- Expression of C4.4A, a structural uPAR homolog, reflects squamous epithelial differentiation in the adult mouse and during embryogenesis (Q35440794) (← links)
- The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis (Q35949789) (← links)
- Stroma targeting nuclear imaging and radiopharmaceuticals (Q35999606) (← links)
- Sense p16 and antisense uPAR bicistronic construct inhibits angiogenesis and induces glioma cell death. (Q36007325) (← links)
- A flexible multidomain structure drives the function of the urokinase-type plasminogen activator receptor (uPAR) (Q36298409) (← links)
- The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain. (Q36585939) (← links)
- Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells. (Q37109384) (← links)
- Revisiting the biological roles of PAI2 (SERPINB2) in cancer (Q37189305) (← links)
- Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases (Q37419308) (← links)
- Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels. (Q37503726) (← links)
- Urokinase plasminogen activator system as a potential target for cancer therapy. (Q37630593) (← links)
- Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis (Q37686524) (← links)
- A novel tumor targeting drug carrier for optical imaging and therapy (Q37695404) (← links)
- Small-molecule modulators of zymogen activation in the fibrinolytic and coagulation systems (Q37780797) (← links)
- Radiometallated Peptides Targeting Guanylate Cyclase C and the Urokinase-Type Plasminogen Activator Receptor (Q37783622) (← links)
- Structure-driven design of radionuclide tracers for non-invasive imaging of uPAR and targeted radiotherapy. The tale of a synthetic peptide antagonist (Q38120755) (← links)
- uPAR peptide antagonist alters regulation of MAP kinases and Bcl-2 family members in favor of apoptosis in MDA-MB-231 cell line (Q38817198) (← links)
- Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo (Q39679559) (← links)
- AP-1-controlled hepatocyte growth factor activation promotes keratinocyte migration via CEACAM1 and urokinase plasminogen activator/urokinase plasminogen receptor (Q39914535) (← links)
- A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines (Q40131728) (← links)
- Elevated plasma urokinase receptor predicts low birth weight in maternal malaria (Q40257524) (← links)
- Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways (Q40309916) (← links)
- Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide (Q40428098) (← links)
- Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor (Q40428669) (← links)
- Regulation of urokinase receptor proteolytic function by the tetraspanin CD82. (Q40464543) (← links)
- RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. (Q40624379) (← links)
- Challenges for drug discovery - a case study of urokinase receptor inhibition (Q41908264) (← links)
- Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy. (Q41978426) (← links)
- Elevated levels of soluble urokinase receptor in serum from mycobacteria infected patients: still looking for a marker of treatment efficacy. (Q44895052) (← links)
- High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test (Q46154986) (← links)
- Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR). (Q46959722) (← links)
- Lack of plasminogen leads to milk stasis and premature mammary gland involution during lactation (Q50716839) (← links)